Literature DB >> 8152796

Loss of heterozygosity and homozygous deletions on 9p21-22 in melanoma.

E A Holland1, S C Beaton, B G Edwards, R F Kefford, G J Mann.   

Abstract

Recent studies have implicated chromosome 9p21-22 as a location for a gene involved in cutaneous melanoma (CM). Deletion mapping in 35 matched tumour-constitutional DNA pairs from metastatic melanomas (including one melanoma cell line) and one dysplastic naevus has been performed using six short tandem repeat polymorphic (STRP) markers (D9S157-D9S162-IFNA-D9S171-DS9126-D9S10 4 ) which span approximately 19 cM across the 9p21-22 region. Both heterozygous and homozygous deletions were observed across the region in melanomas from both sporadic and familial cases. Overall 57% (20/35) of the samples displayed some form of loss. A deletion map identifies two areas of common loss either side of the interferon gene cluster. Familial CM has previously been shown to link to the more proximal of these regions. The deleted region distal to IFNA has not been previously described in melanoma. The results imply the involvement of more than one tumour suppressor gene on 9p in CM.

Entities:  

Mesh:

Year:  1994        PMID: 8152796

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  Molecular clonality of in-transit melanoma metastasis.

Authors:  T Nakayama; B Taback; R Turner; D L Morton; D S Hoon
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

2.  Loss of heterozygosity of microsatellite loci on chromosome 9p in astrocytic tumors and its prognostic implications.

Authors:  M Maruno; T Yoshimine; A K Muhammad; K Tokiyoshi; T Hayakawa
Journal:  J Neurooncol       Date:  1996-10       Impact factor: 4.130

Review 3.  Hepatocarcinogenesis in rodents and humans.

Authors:  T Kitagawa; K Miyasaka; H Kanda; H Yasui; O Hino
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

4.  Circulating DNA microsatellites: molecular determinants of response to biochemotherapy in patients with metastatic melanoma.

Authors:  Bret Taback; Steven J O'Day; Peter D Boasberg; Sherry Shu; Patricia Fournier; Robert Elashoff; He-Jing Wang; Dave S B Hoon
Journal:  J Natl Cancer Inst       Date:  2004-01-21       Impact factor: 13.506

5.  Localization of the CDKN4/p27Kip1 gene to human chromosome 12p12.3.

Authors:  E Martin; V Cacheux; H Cavé; J M Lapierre; D Le Paslier; B Grandchamp
Journal:  Hum Genet       Date:  1995-12       Impact factor: 4.132

6.  Identifying novel homozygous deletions by microsatellite analysis and characterization of tumor suppressor candidate 1 gene, TUSC1, on chromosome 9p in human lung cancer.

Authors:  Zhihong Shan; Tracy Parker; Jonathan S Wiest
Journal:  Oncogene       Date:  2004-08-26       Impact factor: 9.867

Review 7.  Augmentation of effects of interferon-stimulated genes by reversal of epigenetic silencing: potential application to melanoma.

Authors:  Ernest C Borden
Journal:  Cytokine Growth Factor Rev       Date:  2007-08-06       Impact factor: 7.638

8.  Deletions of the region 17p11-13 in advanced melanoma revealed by cytogenetic analysis and fluorescence in situ hybridization.

Authors:  I Okamoto; H Pirc-Danoewinata; J Ackermann; J Drach; H Schlagbauer Wadl; B Jansen; K Wolff; H Pehamberger; C Marosi
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

9.  TUSC1, a putative tumor suppressor gene, reduces tumor cell growth in vitro and tumor growth in vivo.

Authors:  Zhihong Shan; Abbas Shakoori; Sohrab Bodaghi; Paul Goldsmith; Jen Jin; Jonathan S Wiest
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.